Danaher is buying Masimo in a $10 billion deal aimed toward increasing its diagnostics portfolio and deepening its presence in acute care settings. The transfer displays a broader trade shift towards consolidation and built-in care, as giant healthcare firms search scale and extra steady scientific knowledge inside hospitals.
The put up Danaher Drops $10B to Snatch Masimo in Diagnostics Push appeared first on MedCity Information.
